Basic Information
RNALocate ID: RLID:11000826
RNA Symbol: hsa-miR-24-3p
Localization: Exosome
RNA Information
RNA Name: hsa-miR-24
RNA ID: miRBase:MIMAT0000080
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 20976003
Tissue/Cell Line: Breast cancer cell line (MCF-7)
Method: Microarray
Description: Because of the suggested roles of extracellular miRNAs in signaling and diagnosis, we investigated whether the intracellular and extracellular miRNA composition are the same. To answer this question, we performed microRNA microarray analyses of MCF7 cellular (c) and extracellular (x) RNAs (Figure 2A), and found that about 66% of the released miRNAs are at an abundance that closely reflects the cellular miRNA abundance (Figures 2B and 2C). This finding is in agreement with a model wherein most, but not all miRNAs are released passively by mass action. Data are collected from Figure 2.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01001331 Cytoplasm Nasopharyngeal carcinoma cells 20498841
RLID:01001332 Cytoplasm Cell line (HeLa) 21695135
RLID:01001333 Cytoplasm Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001334 Mitochondrion Myotube 27396686
RLID:01001335 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01001336 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:01001337 Nucleus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001338 Nucleolus Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) 24918059
RLID:01001339 Nucleus Nasopharyngeal carcinoma cells 20498841
RLID:11000823 Apoptotic body Human umbilical vein endothelial cells 19996457
RLID:11000824 Exosome Sera 24978137
RLID:11000825 Exosome Pooled sera 27278097
RLID:11000827 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11000828 Exosome Ovarian follicular fluid 22116803
RLID:11000829 Exosome Plasma 23663360
RLID:11000830 Exosome Human mast cell line (HMC-1) 24009880
RLID:11000831 Microvesicle Plasma 23077538
RLID:11000832 Microvesicle Seminal plasma 23539611
RLID:11000833 Microvesicle Follicular fluid 23666971
RLID:11000834 Microvesicle Hepatoma cells 23771658
RLID-D:11000016 Exosome Blood|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Seminal fluid|Tongue tissue
RLID-D:11000279 Microvesicle Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-24-3p Multiple sclerosis chronic progressive MNDR-E-MI-32530
MNDR hsa-miR-24-3p Colorectal adenocarcinoma MNDR-E-MI-32531
MNDR hsa-miR-24-3p Tongue squamous cell carcinoma MNDR-E-MI-32532
MNDR hsa-miR-24-3p Oral squamous cell carcinoma MNDR-E-MI-32533
MNDR hsa-miR-24-3p Medulloblastoma MNDR-E-MI-32534
MNDR hsa-miR-24-3p B cell lymphoma of malt type MNDR-E-MI-32535
MNDR hsa-miR-24-3p High-grade serous ovarian carcinoma MNDR-E-MI-32536
MNDR hsa-miR-24-3p Lymphoma MNDR-E-MI-32537
MNDR hsa-miR-24-3p Estrogen-receptor positive breast cancer MNDR-E-MI-32538
MNDR hsa-miR-24-3p Estrogen-receptor negative breast cancer MNDR-E-MI-32539
MNDR hsa-miR-24-3p Progesterone-receptor negative breast cancer MNDR-E-MI-32540
MNDR hsa-miR-24-3p Her2-receptor positive breast cancer MNDR-E-MI-32541
MNDR hsa-miR-24-3p Breast cancer luminal MNDR-E-MI-32542
MNDR hsa-miR-24-3p Anencephaly MNDR-E-MI-32543
MNDR hsa-miR-24-3p Niemann-pick disease type c MNDR-E-MI-32544
MNDR hsa-miR-24-3p Precursor cell lymphoblastic leukemia-lymphoma MNDR-E-MI-32545
MNDR hsa-miR-24-3p Osteomyelitis MNDR-E-MI-32546
MNDR hsa-miR-24-3p Dermatomyositis MNDR-E-MI-32547
MNDR hsa-miR-24-3p Prostate cancer MNDR-E-MI-32548
MNDR hsa-miR-24-3p Gastric cancer MNDR-E-MI-32549
MNDR hsa-miR-24-3p Alzheimer disease MNDR-E-MI-32550
MNDR hsa-miR-24-3p Intracranial aneurysm MNDR-E-MI-32551
MNDR hsa-miR-24-3p Bladder cancer MNDR-E-MI-32552
MNDR hsa-miR-24-3p Esophageal carcinoma MNDR-E-MI-32553
MNDR hsa-miR-24-3p Dysautonomia familial MNDR-E-MI-32554
MNDR hsa-miR-24-3p Cardiovascular disease MNDR-E-MI-32555
MNDR hsa-miR-24-3p Carotid stenosis MNDR-E-MI-32556
MNDR hsa-miR-24-3p Lung cancer MNDR-E-MI-32557
MNDR hsa-miR-24-3p Down syndrome MNDR-E-MI-32558
MNDR hsa-miR-24-3p Parkinson disease MNDR-E-MI-32559
MNDR hsa-miR-24-3p Niemann-pick disease MNDR-E-MI-32560
MNDR hsa-miR-24-3p Basal-like breast cancer MNDR-E-MI-32561
MNDR hsa-miR-24-3p Thyroid cancer MNDR-E-MI-32562
MNDR hsa-miR-24-3p Pituitary neoplasms MNDR-E-MI-32563
MNDR hsa-miR-24-3p Pancreatic cancer MNDR-E-MI-32564
MNDR hsa-miR-24-3p Melanoma MNDR-E-MI-32565
MNDR hsa-miR-24-3p Rectum adenocarcinoma MNDR-E-MI-32566
MNDR hsa-miR-24-3p Colon cancer MNDR-E-MI-32567
MNDR hsa-miR-24-3p Ischemic attack transient MNDR-E-MI-32568
MNDR hsa-miR-24-3p Colon adenocarcinoma MNDR-E-MI-32569
MNDR hsa-miR-24-3p West nile virus infection MNDR-E-MI-32570
MNDR hsa-miR-24-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-32571
MNDR hsa-miR-24-3p Familial ovarian cancer MNDR-E-MI-32572
MNDR hsa-miR-24-3p Prostate adenocarcinoma MNDR-E-MI-32573
MNDR hsa-miR-24-3p Laryngeal squamous cell carcinoma MNDR-E-MI-32574
MNDR hsa-miR-24-3p Invasive ductal carcinoma MNDR-E-MI-32575
MNDR hsa-miR-24-3p Glioblastoma MNDR-E-MI-32576
MNDR hsa-miR-24-3p Astrocytoma MNDR-E-MI-32577
MNDR hsa-miR-24-3p Glioma MNDR-E-MI-32578
MNDR hsa-miR-24-3p Chronic obstructive pulmonary disease MNDR-E-MI-32579
MNDR hsa-miR-24-3p Chordoma MNDR-E-MI-32580
MNDR hsa-miR-24-3p Amyotrophic lateral sclerosis MNDR-E-MI-32581
MNDR hsa-miR-24-3p Osteosarcoma MNDR-E-MI-32582
MNDR hsa-miR-24-3p Liposarcoma MNDR-E-MI-32583
MNDR hsa-miR-24-3p Coronary artery disease MNDR-E-MI-32584
MNDR hsa-miR-24-3p Inclusion body myositis MNDR-E-MI-32585
MNDR hsa-miR-24-3p Pancreatic ductal adenocarcinoma MNDR-E-MI-32586
MNDR hsa-miR-24-3p Meningioma MNDR-E-MI-32587
MNDR hsa-miR-24-3p Liver cancer MNDR-E-MI-32588
MNDR hsa-miR-24-3p Uterine cancer MNDR-E-MI-32589
MNDR hsa-miR-24-3p Cervical squamous cell carcinoma MNDR-E-MI-32590
MNDR hsa-miR-24-3p Pituitary adenoma MNDR-E-MI-32591
MNDR hsa-miR-24-3p Lung squamous cell carcinoma MNDR-E-MI-32592
MNDR hsa-miR-24-3p Lung adenocarcinoma MNDR-E-MI-32593
MNDR hsa-miR-24-3p Thyroid carcinoma MNDR-E-MI-32594
MNDR hsa-miR-24-3p Ovarian carcinoma MNDR-E-MI-32595
MNDR hsa-miR-24-3p Myasthenia gravis autoimmune experimental MNDR-E-MI-32596
MNDR hsa-miR-24-3p Carcinoma renal cell MNDR-E-MI-32597
MNDR hsa-miR-24-3p Kidney renal papillary cell carcinoma MNDR-E-MI-32598
MNDR hsa-miR-24-3p Clear cell renal cell carcinoma MNDR-E-MI-32599
MNDR hsa-miR-24-3p Biliary tract cancer MNDR-E-MI-32600
MNDR hsa-miR-24-3p Intrahepatic cholangiocarcinoma MNDR-E-MI-32601
MNDR hsa-miR-24-3p Cholangiocarcinoma MNDR-E-MI-32602
MNDR hsa-miR-24-3p Pancreatitis MNDR-E-MI-32603
MNDR hsa-miR-24-3p Esophageal cancer MNDR-E-MI-32604
MNDR hsa-miR-24-3p Liver cirrhosis MNDR-E-MI-32605
MNDR hsa-miR-24-3p Lung small cell carcinoma MNDR-E-MI-32606
MNDR hsa-miR-24-3p Schizophrenia MNDR-E-MI-32607
MNDR hsa-miR-24-3p Head and neck squamous cell carcinoma MNDR-E-MI-32608
MNDR hsa-miR-24-3p Heart failure MNDR-E-MI-32609
MNDR hsa-miR-24-3p Encephalomyelitis MNDR-E-MI-32610
MNDR hsa-miR-24-3p Early hepatocellular carcinoma MNDR-E-MI-32611
MNDR hsa-miR-24-3p Familiar ovarian carcinoma MNDR-E-MI-32612
MNDR hsa-miR-24-3p B-cell lymphoma MNDR-E-MI-32613
MNDR hsa-miR-24-3p Rheumatoid arthritis MNDR-E-MI-32614
MNDR hsa-miR-24-3p Barrett's adenocarcinoma MNDR-E-MI-32615
MNDR hsa-miR-24-3p Hodgkin lymphoma MNDR-E-MI-32616
MNDR hsa-miR-24-3p Ulcerative colitis MNDR-E-MI-32617
MNDR hsa-miR-24-3p Burkitt lymphoma MNDR-E-MI-32618
MNDR hsa-miR-24-3p Acute myelocytic leukemia MNDR-E-MI-32619
MNDR hsa-miR-24-3p Colorectal cancer MNDR-E-MI-32620
MNDR hsa-miR-24-3p Nasopharynx carcinoma MNDR-E-MI-32621
MNDR hsa-miR-24-3p Type 2 diabetes mellitus MNDR-E-MI-32622
MNDR hsa-miR-24-3p Multiple myeloma MNDR-E-MI-32623
MNDR hsa-miR-24-3p Leukemia lymphoblastic acute MNDR-E-MI-32624
MNDR hsa-miR-24-3p Ependymoma MNDR-E-MI-32625
MNDR hsa-miR-24-3p Hearing loss noise-induced MNDR-E-MI-32626
MNDR hsa-miR-24-3p Cardiac hypertrophy MNDR-E-MI-32627
MNDR hsa-miR-24-3p Nasopharyngeal cancer MNDR-E-MI-32628
MNDR hsa-miR-24-3p Prostatic neoplasms MNDR-E-MI-32629
MNDR hsa-miR-24-3p Sleep deprivation MNDR-E-MI-32630
MNDR hsa-miR-24-3p Hypersomnolence idiopathic MNDR-E-MI-32631
MNDR hsa-miR-24-3p Intracranial hemorrhage hypertensive MNDR-E-MI-32632
MNDR hsa-miR-24-3p Vesicular stomatitis MNDR-E-MI-32633
MNDR hsa-miR-24-3p Sarcopenia MNDR-E-MI-32634
MNDR hsa-miR-24-3p Stroke lacunar MNDR-E-MI-32635
MNDR hsa-miR-24-3p Barrett's carcinogenesis MNDR-E-MI-32636
MNDR hsa-miR-24-3p Breast cancer her3+ negative MNDR-E-MI-32637
MNDR hsa-miR-24-3p High grade dysplastic nodule MNDR-E-MI-32638
MNDR hsa-miR-24-3p Solid-pseudopapillary neoplasm of pancreas MNDR-E-MI-32639
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ABCB9 Homo sapiens RR00023201
TOP